UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) May 10, 2004
ENDOLOGIX, INC.
(Exact name of registrant as specified in its charter)
| | | | | |
| DELAWARE | | 0-28440 | | 68-0328265 |
| |
| |
|
(State or other jurisdiction
of incorporation) | | (Commission File Number) | | (IRS Employer
Identification No.) |
| | | |
13900 ALTON PARKWAY, SUITE 122
IRVINE, CA | | 92618 |
| |
|
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code (949) 595-7200
TABLE OF CONTENTS
Item 7. Financial Statements and Exhibits.
| 99.1 | | Press Release, dated May 10, 2004, issued by Endologix, Inc. |
Item 9. Regulation FD Disclosure.
The information included in this section is intended to be included under “Item 12. Disclosure of Results of Operations and Financial Condition” and is included under this Item 9 in accordance with SEC Release No. 33-8216.
On May 10, 2004, Endologix, Inc. announced financial results for the first quarter ended March 31, 2004. A copy of the press release making this announcement is attached hereto as Exhibit 99.1 and incorporated herein by reference. The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | | |
| | ENDOLOGIX, INC.
| |
| Date: May 12, 2004 | By: | /s/ David Richards | |
| | | Chief Financial Officer | |
| | | and Secretary | |
3
EXHIBIT INDEX
| | | |
| Exhibit 99.1 | | Earnings Release of Endologix, Inc. dated May 10, 2004 |
4
